HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Monday, 13 April 2015

Recently published CEAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  From the ones listed this time, here's a few in our areas of research interest:

Charokopou M, McEwan P, Lister S, et. al. The cost-effectiveness of dapagliflozin versus sulfonylurea as an add-on to metformin in the treatment of Type 2 diabetes mellitus. Diabet Med. 2015 Mar 28. [Epub ahead of print] PubMed PMID: 25817050.

Joensuu JT, Huoponen S, Aaltonen KJ, et. al. The cost-effectiveness of biologics for the treatment of rheumatoid arthritis: a systematic review. PLoS One. 2015 Mar 17;10(3):e0119683. eCollection 2015. PubMed PMID: 25781999.

Yeh JM, Hur C, Ward Z, et. al. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis. Gut. 2015 Mar 16. [Epub ahead of print] PubMed PMID: 25779597.